Cargando…
PB2280: MULTISYSTEM ERDHEIM CHESTER NEOPLASM WITH BRAFV660E MUTATION, PROMINENT EMPERIPOLESIS, HEMOPHAGOCYTOSIS AND FULMINANT COURSE
Autores principales: | Soliman, Dina, Ibrahim, Firyal, Rizvi, Hasan, Lengyel, Zsolt, Alshurafa, Awni, Petkar, Mahir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429758/ http://dx.doi.org/10.1097/01.HS9.0000975852.20317.08 |
Ejemplares similares
-
Erdheim-Chester Disease with Emperipolesis: A Unique Case Involving the Heart
por: Zhu, Pengcheng, et al.
Publicado: (2017) -
FDA Approval Summary: Vemurafenib for the Treatment of Patients with Erdheim‐Chester Disease with the BRAFV600 Mutation
por: Oneal, Patricia A., et al.
Publicado: (2018) -
Erdheim-Chester Disease
por: Yamamoto, Shinya, et al.
Publicado: (2019) -
Multisystem Radiologic Manifestations of Erdheim-Chester Disease
por: Lodhi, Umairullah, et al.
Publicado: (2016) -
Prominent emperipolesis in breast lesion: A diagnostic challenge
por: Sahai, Rishabh, et al.
Publicado: (2023)